Human Genome Epidemiology Literature Finder
|
Records 1 - 3 (of 3 Records) |
| Query Trace: Neoplasms and meta-analysis and PCSK9[original query] |
|---|
| Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer. JAMA 2020 Feb 323 (7): 646-655. Yarmolinsky James, Bull Caroline J, Vincent Emma E, Robinson Jamie, Walther Axel, Smith George Davey, Lewis Sarah J, Relton Caroline L, Martin Richard |
| PCSK9 loss of function is protective against extra-coronary atherosclerotic cardiovascular disease in a large multi-ethnic cohort. PloS one 2020 11 15 (11): e0239752. Small Aeron M, Huffman Jennifer E, Klarin Derek, Lynch Julie A, Assimes Themistocles, DuVall Scott, Sun Yan V, Shere Labiba, Natarajan Pradeep, Gaziano Michael, Rader Daniel J, Wilson Peter W F, Tsao Philip S, Chang Kyong-Mi, Cho Kelly, O'Donnell Christopher J, Casas Juan P, Damrauer Scott M, |
| Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer. Breast cancer research : BCR 2022 Feb 24 (1): 12. Sun Lulu, Ding Huan, Jia Yiming, Shi Mengyao, Guo Daoxia, Yang Pinni, Wang Yu, Liu Fanghua, Zhang Yonghong, Zhu Zhengb |
- Page last reviewed:Feb 1, 2024
- Content source:

